61.36
Schlusskurs vom Vortag:
$59.94
Offen:
$60.29
24-Stunden-Volumen:
416.46K
Relative Volume:
0.92
Marktkapitalisierung:
$2.95B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$213.00M
KGV:
14.40
EPS:
4.2622
Netto-Cashflow:
$267.84M
1W Leistung:
+1.79%
1M Leistung:
+1.49%
6M Leistung:
-29.18%
1J Leistung:
-27.15%
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Vergleichen Sie PBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PBH
Prestige Consumer Healthcare Inc
|
61.36 | 2.88B | 1.12B | 213.00M | 267.84M | 4.2622 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
| 2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
| 2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-07 | Fortgesetzt | Sidoti | Neutral |
| 2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-24 | Eingeleitet | Oppenheimer | Perform |
| 2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
| 2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
| 2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
| 2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
| 2014-04-28 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Here’s why analysts are positive on Prestige Consumer Healthcare Inc. (PBH) - MSN
Here’s Why Analysts Are Positive On Prestige Consumer Healthcare Inc. (PBH) - Insider Monkey
Implied Volatility Surging for Prestige Consumer Stock Options - TradingView
Brandes Small Cap Value Fund Initiated a Position in Prestige Consumer Healthcare (PBH) on a Dip - Insider Monkey
What drives Prestige Consumer Healthcare Inc stock priceLow Beta Stocks & High Yield Portfolio Growth - earlytimes.in
Wall Street Analysts Believe Prestige Consumer Healthcare (PBH) Could Rally 26.06%: Here's is How to Trade - Finviz
Prestige Consumer Healthcare Earnings Notes - Trefis
Will Prestige Consumer Healthcare Inc. (PBV) stock deliver stable dividendsEntry Point & Safe Entry Momentum Tips - Newser
Can Prestige Consumer Healthcare Inc. (PBV) stock sustain revenue momentumJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
What market sentiment indicators show for Prestige Consumer Healthcare Inc. stockJuly 2025 Outlook & Safe Capital Preservation Plans - Newser
Why retail traders accumulate Prestige Consumer Healthcare Inc. stockJuly 2025 Sentiment & Stock Market Timing Techniques - Newser
Is Prestige Consumer Healthcare Inc. stock prepared for digital transitionJuly 2025 Pullbacks & Low Drawdown Momentum Ideas - Newser
Will Prestige Consumer Healthcare Inc. (PBV) stock benefit from sector leadershipWeekly Risk Summary & Smart Allocation Stock Reports - Newser
Franklin Resources Inc. Increases Position in Prestige Consumer Healthcare Inc. $PBH - Defense World
Who are in the management team of Prestige Consumer Healthcare, Inc.? - Markets Mojo
Insider Selling: Prestige Consumer Healthcare (NYSE:PBH) VP Sells 281 Shares of Stock - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) VP Jeffrey Zerillo Sells 719 Shares - MarketBeat
Fecal Incontinence Therapeutics Market Rapied Growth in GCC - openPR.com
Fisher Asset Management LLC Lowers Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Senior VP Operations Sells Shares - TradingView
VP Zerillo Sells 1,000 ($60K) Of Prestige Consumer Healthcare Inc [PBH] - TradingView
Prestige Consumer Healthcare (PBH) officer reports stock sales in Form 4 filing - Stock Titan
Pullback Watch: Is Prestige Consumer Healthcare Inc stock a top momentum playQuarterly Profit Summary & Low Risk Entry Point Guides - BỘ NỘI VỤ
Edgestream Partners L.P. Makes New Investment in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. $PBH Shares Acquired by Rhumbline Advisers - MarketBeat
How analysts revise price targets for Prestige Consumer Healthcare Inc. (PBV) stockJuly 2025 Setups & Low Risk Profit Maximizing Plans - Newser
Aug Reactions: Why global investors buy Prestige Consumer Healthcare Inc. (PBV) stock2025 Institutional Moves & Low Risk Profit Maximizing Plans - BỘ NỘI VỤ
VP Zerillo Files To Sell 281 Of Prestige Consumer Healthcare Inc [PBH] - TradingView
PBH (NYSE: PBH) insider files Rule 144 to sell 281 common shares - Stock Titan
Understanding the Setup: (PBH) and Scalable Risk - news.stocktradersdaily.com
Wall Street Recap: What makes Prestige Consumer Healthcare Inc. (PBV) stock appealing to growth investors2025 Year in Review & Capital Efficient Trade Techniques - BỘ NỘI VỤ
PBH (NYSE: PBH) investor files Form 144 to sell 719 common shares - Stock Titan
Zacks Research Analysts Raise Earnings Estimates for PBH - Defense World
Sell Alert: John E Byom Cashes Out $178K In Prestige Consumer Stock - Benzinga
Insider Sell: John Byom Sells 3,000 Shares of Prestige Consumer Healthcare Inc (PBH) - GuruFocus
Is Prestige Consumer Healthcare Inc. stock a top momentum play2025 Market Overview & Short-Term Trading Alerts - BỘ NỘI VỤ
Why Prestige Consumer Healthcare Inc. stock remains top rated2025 Short Interest & Accurate Entry and Exit Point Alerts - BỘ NỘI VỤ
What analysts say about Prestige Consumer Healthcare Inc stockHigh Dividend Yield Stocks & Low Cost Trading Ideas - earlytimes.in
Dir Byom Sells 3,000 ($178.1K) Of Prestige Consumer Healthcare Inc [PBH] - TradingView
[Form 4] Prestige Consumer Healthcare Inc. Insider Trading Activity - Stock Titan
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly - 富途牛牛
Risk-to-Price Commentary: Prestige Brands Inc. - S&P Global
[144] Prestige Consumer Healthcare Inc. SEC Filing - Stock Titan
Dir Byom Files To Sell 3,000 Of Prestige Consumer Healthcare Inc [PBH] - TradingView
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Contrasting Prestige Consumer Healthcare (NYSE:PBH) and Cresco Labs (OTCMKTS:CRLBF) - Defense World
Prestige Consumer Healthcare Beats Q2 Expectations and Raises EPS Guidance - MSN
Magnetar Financial LLC Acquires 38,648 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige consumer healthcare EVP sells $959,270 in stock - MSN
Geode Capital Management LLC Has $112.84 Million Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo Finance
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):